Fig. 7

lncRNA FAF mitigates chemotherapy-induced cardiomyocyte injury by inhibiting pyroptosis. (A) Nigericin inhibited the viability of DOX- and oe-lncRNA FAF-treated rat cardiomyocytes; (B-C) Representative flow cytometric speckle plots and quantification showing the percentage of pyroptosis cells; (D) Representative WB electropherograms of NLRP3, C-Caspase1, and GSDMD-N; N = 3.